british compani said find support use
retrovir known clinic zidovudin use combat
effect human immunodefici virus
earlier stage hiv infect broaden use
potenti market
wellcom said wider applic would still requir
regulatori approv trial result wo
impact compani current revenu still
announc sent pharmaceut concern share surg
24 penc 11.74 $ 20.97 late trade london stock
exchang
clinic trial wellcom said preliminari result
show probabl diseas progress two
year treatment 28 % recipi placebo
14 % treat retrovir full analysi
drug trial expect confirm find
wellcom said
